The Interaction of Nuclear Factor-Kappa B and Cytokines Is Associated with Schizophrenia

  title={The Interaction of Nuclear Factor-Kappa B and Cytokines Is Associated with Schizophrenia},
  author={Xueqin Song and Lu-xian Lv and Wenqiang Li and Yi-hui Hao and Jing-ping Zhao},
  journal={Biological Psychiatry},

Figures and Tables from this paper

A Study of Nuclear Factor-Kappa B1 Gene Polymorphism Types in Schizophrenia Patients and Their Correlation With Disease Severity
It was found that in schizophrenia patients, the insertion allele was higher than the deletion allele and the ins/ins genotype was higher in frequency than the del/del and ins/del genotypes.
IL-4, TGF-, NF-B and MPO levels in Patients with Treatment Resistant Schizophrenia.
The low TGF- level in treatment-resistant schizophrenia patients in the symptom exacerbation period indicates that there is inadequate Th1/Th2 balance and plays a role in the disorder's physiopathology from the beginning.
Altered Serum Tumor Necrosis Factor and Interleukin-1β in First-Episode Drug-Naive and Chronic Schizophrenia
Increased TNF-α and IL-1β levels in chronic patients may be associated with the progression, psychotropic drugs or other factors occur during chronic stage, and immune modulating treatments may become a new strategy of therapy for this subgroup of patients.
Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases
It is found that elevations in TLR4 and RelB appear more related to inflammatory status than to a diagnosis of schizophrenia, but changes in TNFR2 occur in both the high and low inflammation patients (but were exaggerated in high inflammation patients).
Relationship of serum levels of TNF-α, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers
Neuroinflammation in schizophrenia: the role of nuclear factor kappa B
Though the ubiquitous nature of NF-κB presents several hurdles for drug development, targeting this key immunoregulator with novel or repurposed therapeutics in schizophrenia is a relatively underexplored area that could aid in reducing symptoms of patients with active neuroinflammation.
Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia
Findings showed abnormal expression of IDO levels which correlated with negative symptoms and pro-inflammatory cytokine levels in patients with first-episode drug-naive schizophrenia, suggesting the important role ofIDO in the pathological mechanism of schizophrenia.
Increased interleukin-6 level in Taiwanese schizophrenic patients.
An increase in the IL-6 level may play a role in the pathophysiology of schizophrenia, and a larger sample size and a longer period of follow-up are needed to confirm this finding.
Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6
The present results provide further support for the hypothesis of an involvement of a dysfunction of the monocytic system in the pathophysiology of schizophrenia and indicate that especially the pro-inflammatory immune response seems to be impaired.
Variants of the RELA Gene are Associated with Schizophrenia and their Startle Responses
The pathogenesis of schizophrenia is thought to involve aberrant immune and inflammatory responses. Nuclear factor kappa B (NF-κB) has important roles in the immune and inflammatory responses. The


A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia?
Circulating levels of TNF alpha and IL-6 were significantly higher in patients than in controls and did not result from variations of its antagonist levels, suggesting a specific cytokine-mediated syndrome in schizophrenia.
Monocytic, Th1 and Th2 Cytokine Alterations in the Pathophysiology of Schizophrenia
The results suggest that increased monocytic cytokines and decreased Th1 and Th2 cytokines may be associated with the immunopathogenesis of acute psychotic schizophrenia, and that antipsychotics may play an important role in immune response by decreasing elevated monocytical cytokines.
Roles of nuclear factor kappaB in neuronal survival and plasticity.
The available data identify NF-kappaB as an important regulator of evolutionarily conserved biochemical and molecular cascades designed to prevent cell death and promote neuronal plasticity.
The role of nuclear factor-kappa B in cytokine gene regulation.
This work has shown that activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models.
Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia.
Both typical and atypical anti-psychotic drugs may at least partially normalize abnormal immune alterations in schizophrenia and some immune parameters at baseline may be useful for predicting the neuroleptic response of schizophrenic patients.